Use of medication during pregnancy
33 results
1 - 33
Antiviral medication exposure safe in first trimester of pregnancy- SSRI use during pregnancy may increase risk of speech/language disorders in offspring
- Ondansetron use in pregnancy associated with small increased risk of oral clefts
- Maternal triptan use during pregnancy is not associated with risk of attention-deficit/hyperactivity disorder in offspring
- Zolpidem associated with adverse pregnancy outcomes
- Periconception antibiotics associated with birth defects
- Prescription stimulant use during pregnancy is unlikely to harm offspring
- No increased risk of ASD, ADHD, or SGA with first-trimester antidepressant use
- Prenatal exposure to pregabalin associated with major birth defects
- Similar risk of major malformations in infants of asthmatic women with alternate treatment regimens
- Paternal use of valproate is not associated with adverse outcomes among offspring
- First-trimester intranasal triamcinolone increases risk of respiratory system malformations
- Maternal prebiotics supplementation during pregnancy and lactation does not reduce infant allergic disease
- In utero SSRI associated with adverse perinatal events
- Pre-exposure prophylaxis for HIV prevention does not improve pregnancy outcomes
- Pregnancy complications can be identified using masked ultrasound sweeps
- Autism not linked to thimerosol in vaccines
- Newer-generation antiepileptic drugs not associated with risk of major birth defects
- Buprenorphine combined with naloxone is safe and effective for opioid use disorder in pregnancy
- Cycling during pregnancy reduced the rate of GDM in overweight and obese women
- Vitamin D supplementation during pregnancy does not prevent asthma in offspring
- Early = delayed oxytocin for dysfunctional labor
- Prenatal cannabis exposure is not associated with an increased incidence of several neuropsychiatric disorders
- Conservative treatment of first-degree perineal tears after delivery is a reasonable option
- No increased risks with Tdap in pregnant women with recent (< 5 years) history of prior Tdap
- Maternal gestational diabetes before 26 weeks' associated with risk of ASD
- Low-dose aspirin beneficial for the prevention of preterm birth in nulliparas with singleton pregnancy
- 17-OHPC may not reduce recurrent preterm birth or decrease neonatal morbidity
- Noninvasive bioelectronic treatment reduces opioid use among patients after cesarean delivery
- COVID-19 research briefs: asymptomatic carriage during pregnancy is common, and unclear efficacy evidence for homemade masks
- Cervical-uterine instillation with mepivacaine modestly reduces pain during intrauterine device insertion